Lobbying Relationship

Client

McKesson Corporation

More records

Lobbying firm

Akin, Gump, Strauss, Hauer & Feld

More records

  • Issues related to COVID medical response; COVID-19 vaccine distribution; and health disparities; H.R. 7667, Food & Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.
  • Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act.

Duration: to

General Issues: Health Issues, Pharmacy, Medicare/Medicaid

Spending: about $690,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, House of Representatives

Bills mentioned

H.R.748: CARES Act

Sponsor: Joe Courtney (D-Conn.)

H.R.6800: The Heroes Act

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

H.R.748: Ethan's Law

Sponsor: Rosa DeLauro (D-Conn.)

H.R.133: David’s Law

Sponsor: Sheila Jackson Lee (D-Texas)

S.1362: Pharmacy and Medically Underserved Areas Enhancement Act

Sponsor: Charles E. Grassley (R-Iowa)

H.R.7667: Food and Drug Amendments of 2022

Sponsor: Anna G. Eshoo (D-Calif.)

S.4348: FDASLA Act of 2022

Sponsor: Patty Murray (D-Wash.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Virgil Miller Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19.
Chris Treanor Pol Analyst, Energy & Env, H Energy & Commerce Comm
Louis Agnello Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08
Jose Borjon CoS, Rep V.Gonzalez, Jan 17- Feb 21; Snr Advsr/Dpty CoS, Rep F.Vela, Jun 14- Jan 17; Comm Drctr, Rep Gallego, Dec 13- Jan 15; Drctr Strtgy/Comm, Rep Reyes, Nov 11- Jan 13; Press Sec, Rep Cuellar, Jan 11- Nov 11; Comm Drctr, Rep Ortiz, Mar 09- Jan 11
Sean D'Arcy n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page